Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
John A BridgewaterPeter FletcherDaniel H PalmerHassan Z MalikK Raj PrasadDarius F MirzaAlan AnthonyPhilippa CorrieStephen FalkMeg Finch-JonesHarpreet S WasanPaul J RossLucy WallJonathan WadsleyThomas R EvansDeborah StockenClive StubbsRaaj PraseedomYuk Ting MaBrian R DavidsonJohn P NeoptolemosTimothy J IvesonDavid CunninghamO James GardenJuan W ValleJohn N Primrosenull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
This long-term analysis supports the previous analysis, suggesting that capecitabine can improve OS in patients with resected BTC when used as adjuvant chemotherapy after surgery and should be considered as the standard of care.